Cargando…
Intranasal type I interferon treatment is beneficial only when administered before clinical signs onset in the SARS-CoV-2 hamster model
Impaired type I interferons (IFNs) production or signaling have been associated with severe COVID-19, further promoting the evaluation of recombinant type I IFNs as therapeutics against SARS-CoV-2 infection. In the Syrian hamster model, we show that intranasal administration of IFN-α starting one da...
Autores principales: | Bessière, Pierre, Wasniewski, Marine, Picard-Meyer, Evelyne, Servat, Alexandre, Figueroa, Thomas, Foret-Lucas, Charlotte, Coggon, Amelia, Lesellier, Sandrine, Boué, Frank, Cebron, Nathan, Gausserès, Blandine, Trumel, Catherine, Foucras, Gilles, Salguero, Francisco J., Monchatre-Leroy, Elodie, Volmer, Romain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376007/ https://www.ncbi.nlm.nih.gov/pubmed/34370799 http://dx.doi.org/10.1371/journal.ppat.1009427 |
Ejemplares similares
-
Hamster and ferret experimental infection with intranasal low dose of a single strain of SARS-CoV-2
por: Monchatre-Leroy, Elodie, et al.
Publicado: (2021) -
Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters
por: Bryche, Bertrand, et al.
Publicado: (2020) -
OVX033, a nucleocapsid-based vaccine candidate, provides broad-spectrum protection against SARS-CoV-2 variants in a hamster challenge model
por: Primard, Charlotte, et al.
Publicado: (2023) -
EPAC1 Pharmacological Inhibition with AM-001 Prevents SARS-CoV-2 and Influenza A Virus Replication in Cells
por: Foret-Lucas, Charlotte, et al.
Publicado: (2023) -
Th17-related mammary immunity, but not a high systemic Th1 immune response is associated with protection against E. coli mastitis
por: Cebron, Nathan, et al.
Publicado: (2020)